Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 24 studies | 28% ± 11% | |
| macrophage | 18 studies | 30% ± 16% | |
| fibroblast | 13 studies | 21% ± 8% | |
| mast cell | 12 studies | 26% ± 9% | |
| classical monocyte | 12 studies | 24% ± 10% | |
| monocyte | 11 studies | 28% ± 13% | |
| non-classical monocyte | 11 studies | 28% ± 12% | |
| glutamatergic neuron | 11 studies | 42% ± 26% | |
| oligodendrocyte | 11 studies | 36% ± 14% | |
| endothelial cell of lymphatic vessel | 9 studies | 31% ± 11% | |
| basal cell | 9 studies | 28% ± 10% | |
| adipocyte | 9 studies | 39% ± 12% | |
| astrocyte | 9 studies | 35% ± 16% | |
| microglial cell | 9 studies | 31% ± 13% | |
| type I pneumocyte | 8 studies | 23% ± 8% | |
| GABAergic neuron | 8 studies | 47% ± 23% | |
| myeloid cell | 8 studies | 37% ± 11% | |
| ciliated cell | 8 studies | 26% ± 10% | |
| oligodendrocyte precursor cell | 8 studies | 37% ± 16% | |
| B cell | 6 studies | 25% ± 7% | |
| epithelial cell | 6 studies | 40% ± 15% | |
| club cell | 6 studies | 30% ± 10% | |
| dendritic cell | 6 studies | 31% ± 12% | |
| type II pneumocyte | 6 studies | 25% ± 7% | |
| interneuron | 6 studies | 46% ± 25% | |
| natural killer cell | 5 studies | 19% ± 3% | |
| lymphocyte | 5 studies | 23% ± 6% | |
| retina horizontal cell | 5 studies | 25% ± 9% | |
| neuron | 5 studies | 43% ± 16% | |
| smooth muscle cell | 5 studies | 19% ± 2% | |
| secretory cell | 4 studies | 23% ± 6% | |
| retinal ganglion cell | 4 studies | 30% ± 7% | |
| amacrine cell | 4 studies | 21% ± 4% | |
| cardiac muscle cell | 4 studies | 20% ± 1% | |
| retinal rod cell | 4 studies | 22% ± 4% | |
| respiratory goblet cell | 4 studies | 35% ± 10% | |
| regulatory T cell | 4 studies | 18% ± 2% | |
| alveolar macrophage | 4 studies | 46% ± 19% | |
| pericyte | 4 studies | 24% ± 7% | |
| hematopoietic precursor cell | 3 studies | 24% ± 5% | |
| squamous epithelial cell | 3 studies | 36% ± 27% | |
| retinal pigment epithelial cell | 3 studies | 33% ± 22% | |
| mononuclear phagocyte | 3 studies | 25% ± 13% | |
| GABAergic amacrine cell | 3 studies | 23% ± 4% | |
| glycinergic amacrine cell | 3 studies | 22% ± 1% | |
| hepatocyte | 3 studies | 36% ± 20% | |
| neural progenitor cell | 3 studies | 22% ± 6% | |
| connective tissue cell | 3 studies | 17% ± 1% | |
| ependymal cell | 3 studies | 28% ± 12% | |
| myofibroblast cell | 3 studies | 19% ± 5% | |
| T cell | 3 studies | 22% ± 2% | |
| goblet cell | 3 studies | 40% ± 33% | |
| vein endothelial cell | 3 studies | 33% ± 20% | |
| granule cell | 3 studies | 26% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 3094.37 | 2634 / 2642 | 100% | 11.44 | 704 / 705 |
| thymus | 100% | 4638.23 | 653 / 653 | 100% | 25.95 | 602 / 605 |
| prostate | 100% | 2753.91 | 245 / 245 | 99% | 15.47 | 498 / 502 |
| esophagus | 100% | 3333.77 | 1445 / 1445 | 98% | 8.91 | 180 / 183 |
| lung | 100% | 3356.69 | 576 / 578 | 99% | 9.96 | 1139 / 1155 |
| kidney | 100% | 2126.48 | 89 / 89 | 98% | 14.39 | 885 / 901 |
| breast | 100% | 3747.37 | 459 / 459 | 97% | 12.26 | 1089 / 1118 |
| adrenal gland | 100% | 4521.49 | 258 / 258 | 97% | 17.58 | 224 / 230 |
| uterus | 100% | 3011.44 | 170 / 170 | 97% | 9.62 | 445 / 459 |
| bladder | 100% | 3524.95 | 21 / 21 | 97% | 8.50 | 487 / 504 |
| stomach | 100% | 2429.26 | 359 / 359 | 97% | 8.17 | 276 / 286 |
| intestine | 100% | 3222.65 | 966 / 966 | 96% | 8.12 | 506 / 527 |
| skin | 100% | 2853.12 | 1808 / 1809 | 95% | 15.25 | 449 / 472 |
| pancreas | 96% | 1303.01 | 314 / 328 | 97% | 9.96 | 173 / 178 |
| ovary | 100% | 2971.55 | 180 / 180 | 90% | 5.86 | 386 / 430 |
| liver | 100% | 1599.69 | 226 / 226 | 85% | 5.62 | 346 / 406 |
| adipose | 100% | 4520.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3234.55 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 8.75 | 29 / 29 |
| muscle | 100% | 4262.38 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3316.55 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.23 | 1 / 1 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 11.30 | 44 / 45 |
| heart | 94% | 1661.25 | 812 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 92% | 3087.54 | 858 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 89% | 12.57 | 71 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1902389 | Biological process | ceramide 1-phosphate transport |
| GO_0120012 | Biological process | intermembrane sphingolipid transfer |
| GO_0008283 | Biological process | cell population proliferation |
| GO_0001701 | Biological process | in utero embryonic development |
| GO_0034976 | Biological process | response to endoplasmic reticulum stress |
| GO_0035621 | Biological process | ER to Golgi ceramide transport |
| GO_0007165 | Biological process | signal transduction |
| GO_0007029 | Biological process | endoplasmic reticulum organization |
| GO_0120009 | Biological process | intermembrane lipid transfer |
| GO_0006672 | Biological process | ceramide metabolic process |
| GO_0035627 | Biological process | ceramide transport |
| GO_0006936 | Biological process | muscle contraction |
| GO_0006955 | Biological process | immune response |
| GO_0007005 | Biological process | mitochondrion organization |
| GO_0055088 | Biological process | lipid homeostasis |
| GO_0000902 | Biological process | cell morphogenesis |
| GO_0003007 | Biological process | heart morphogenesis |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005829 | Cellular component | cytosol |
| GO_0120017 | Molecular function | ceramide transfer activity |
| GO_1902388 | Molecular function | ceramide 1-phosphate transfer activity |
| GO_0097001 | Molecular function | ceramide binding |
| GO_1902387 | Molecular function | ceramide 1-phosphate binding |
| GO_0016301 | Molecular function | kinase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CERT1 |
| Protein name | Ceramide transfer protein (hCERT) (Collagen type IV alpha-3-binding protein) (Goodpasture antigen-binding protein) (GPBP) (START domain-containing protein 11) (StARD11) (StAR-related lipid transfer protein 11) Ceramide transporter 1 Sesquipedalian (Ses) (PH domain-containing endocytic trafficking adaptor) Ceramide transfer protein (Collagen type IV alpha-3-binding protein) |
| Synonyms | COL4A3BP CERT STARD11 |
| Description | FUNCTION: Shelters ceramides and diacylglycerol lipids inside its START domain and mediates the intracellular trafficking of ceramides and diacylglycerol lipids in a non-vesicular manner. . FUNCTION: Plays a role in endocytic trafficking. Required for receptor recycling from endosomes, both to the trans-Golgi network and the plasma membrane. . |
| Accessions | ENST00000642809.1 ENST00000646511.1 [Q9Y5P4-2] A0A2R8Y7Q9 ENST00000405807.10 [Q9Y5P4-3] ENST00000261415.12 [Q9Y5P4-1] A0A2R8Y5H3 ENST00000644516.1 ENST00000642488.1 ENST00000645866.1 A0A2R8YEA4 ENST00000643380.1 A0A2R8YEK8 ENST00000642225.1 Q9Y5P4 ENST00000508809.2 ENST00000380494.10 ENST00000643780.2 [Q9Y5P4-1] ENST00000644377.1 ENST00000645483.1 [Q9Y5P4-2] ENST00000644072.2 [Q9Y5P4-1] A0A2R8YFA1 A0A0A0MRE4 A0A2R8Y773 A0A2R8YE59 A0A2R8YCI0 ENST00000646302.1 H0Y9J1 ENST00000643773.1 A0A2R8Y7C5 ENST00000357457.9 ENST00000644912.1 ENST00000644128.1 A0A2U3TZL3 A0A2R8Y3S9 ENST00000643158.1 ENST00000508692.1 ENST00000644445.1 [Q9Y5P4-2] A0A2R8YFI2 A0A2R8YE18 ENST00000646172.1 A0A2R8YDX6 A0A2R8Y5S9 ENST00000646713.1 ENST00000642556.1 A0A2R8Y5G0 |